Monday, September 14, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 17, 2026

Beat the Market the Zacks Way: Micron Technology, Cooper Companies, Coeur Mining in Focus

View original at finance.yahoo.com
Beat the Market the Zacks Way: Micron Technology, Cooper Companies, Coeur Mining in Focus Last week, the three most widely followed U.S. indexes, the Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average, slipped 2.98%, 1.85% and 1.27%, respectively, facing the worst weekly performance of the year…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Zacks provides investors with unbiased guidance on how to beat the market regardless of market conditions

    80% confidence

  • Stability in the labor market will give the Federal Reserve room to keep the interest rate unchanged for some time

    80% confidence

  • Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements

    80% confidence

  • Massive AI investments might not yield immediate profits, causing investor pivot away from high-growth tech stocks

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,285 source documents archived
Query this data → isubstrate.com
Beat the Market the Zacks Way: Micron Technology, Cooper Companies, Coeur Mining in Focus — Source | Via News | Finance Via News